The pathophysiology of COVID-19 AKI involves very robust local and systemic inflammatory and immune responses leading to endothelial injury and activation of coagulation and the renin–angiotensin system evidenced by a rise in inflammatory markers [17]. This evidence concerns the gene REN and COVID-19.